硬皮病相关间质性肺病的死亡风险预测:SADL模型
本研究从两个纵向队列中识别硬皮病相关间质性肺病患者,推导队列为加州大学旧金山分校135例,验证队列为梅奥诊所90例。研究测试了19个临床预测变量中每3或4个变量组合的所有Cox模型,构建并验证了死亡风险预测模型。最终模型SADL包含三个变量:吸烟史、年龄、一氧化碳弥散量(%预测值);连续模型在推导队列C-index为0.88,验证队列为0.84。研究用合并队列创建了评分系统(C-index 0.82),并据此划分3年死亡低、中、高风险分类。该模型使用简单易得的临床变量预测全因死亡。
要点
- SADL模型仅含吸烟史、年龄、DLCO(%预测值)三个变量,推导队列C-index 0.88,验证队列C-index 0.84。
- 研究基于两个纵向队列:加州大学旧金山分校135例(推导)和梅奥诊所90例(验证)。
- 用合并队列创建评分系统,C-index 0.82,可区分3年死亡低、中、高风险。
- 模型预测的是硬皮病相关间质性肺病患者的全因死亡,不是特定病因死亡。
适用人群与场景
- 硬皮病相关间质性肺病患者,来自两个纵向队列:加州大学旧金山分校135例(推导队列)和梅奥诊所90例(验证队列)。
研究设计与关键结果
- 研究类型为预后模型开发与验证研究,推导队列135例,验证队列90例,测试19个临床预测变量中每3或4个变量的所有Cox模型。
- 最终SADL模型包含吸烟史、年龄、一氧化碳弥散量(%预测值);连续模型推导队列C-index 0.88,验证队列C-index 0.84。
- 用合并队列创建点评分系统,C-index 0.82,并据此划分3年死亡低、中、高风险分类。
证据类型、等级与局限
- 证据类型:预后模型开发与验证研究,基于两个纵向队列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Interstitial lung disease (ILD) is an important cause of morbidity and mortality in patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD are challenging because of heterogeneity in the disease course.
METHODS: We aimed to develop a clinical mortality risk prediction model for Scl-ILD. Patients with Scl-ILD were identified from two ongoing longitudinal cohorts: 135 patients at the University of California, San Francisco (derivation cohort) and 90 patients at the Mayo Clinic (validation cohort). Using these two separate cohorts, a mortality risk prediction model was developed and validated by testing every potential candidate Cox model, each including three or four variables of a possible 19 clinical predictors, for time to death. Model discrimination was assessed using the C-index.
RESULTS: Three variables were included in the final risk prediction model (SADL): ever smoking history, age, and diffusing capacity of the lung for carbon monoxide (% predicted). This continuous model had similar performance in the derivation (C-index, 0.88) and validation (C-index, 0.84) cohorts. We created a point scoring system using the combined cohort (C-index, 0.82) and used it to identify a classification with low, moderate, and high mortality risk at 3 years.
CONCLUSIONS: The SADL model uses simple, readily accessible clinical variables to predict all-cause mortality in Scl-ILD.
参考来源
- Morisset J, Vittinghoff E, Elicker BM, et al. Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model. Chest. 2017. PMID: 28629914. doi:10.1016/j.chest.2017.06.009
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。